Newsroom

HOUSTON--(BUSINESS WIRE)--Genesis Energy, L.P. (NYSE: GEL) today announced that it has filed its Annual Report on Form 10-K for the fiscal year ended December 31, 2025 with the Securities and Exchange Commission. A copy of this Form 10-K may be found on the Partnership’s website at https://www.genesisenergy.com/investors/sec-filings. A hard copy of the Form 10-K may be requested free of charge by emailing InvestorRelations@genlp.com. Genesis Energy, L.P. is a diversified midstream energy master...

NEW YORK--(BUSINESS WIRE)--Starboard Value LP (together with its affiliates, “Starboard”), a significant stockholder of Riot Platforms, Inc. (“Riot Platforms”, “Riot”, or the “Company”) (NASDAQ: RIOT), today announced that it has delivered a letter to Jason Les, Riot Platforms’ Chief Executive Officer, and Benjamin Yi, the Company’s Executive Chairman, with a copy to the Company’s Board of Directors. The full text of Starboard's letter to the Company can be viewed here. About Starboard Value LP...

SAN DIEGO--(BUSINESS WIRE)--The case alleges defendants created the false impression that they possessed reliable information regarding PayPal’s projected revenue and growth....

SAN DIEGO--(BUSINESS WIRE)--The case alleges Enphase Energy misled investors about channel inventory and its ability to mitigate the 25D tax credit's termination....

FORT MYERS, Fla.--(BUSINESS WIRE)--NeoGenomics will participate in the TD Cowen 46th Annual Health Care Conference in Boston and the Leerink Global Healthcare Conference in Miami....

BOSTON--(BUSINESS WIRE)--AcuityMD today announced it has launched AcuityMD for Salesforce on Salesforce AppExchange, the leading enterprise marketplace for partner apps and experts, empowering customers to integrate AcuityMD’s platform directly with Salesforce to help commercial teams identify opportunities, research and prioritize targets, and hit sales goals faster. AcuityMD combines accurate and precise data, AI-powered insights, and intuitive workflows to help commercial teams move faster a...

LEXINGTON, Mass.--(BUSINESS WIRE)--Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated diseases, today announced that Todd C. Brady, M.D., Ph.D., President and Chief Executive Officer, will participate virtually in a fireside chat at the Oppenheimer 36th Annual Healthcare Life Sciences Conference. Dr. Brady’s conversation with Andreas Argyrides, Managing Director, Senior Biotech...

WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories Announces Executive Appointments...

DURHAM, N.C.--(BUSINESS WIRE)--Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for high unmet need diseases, today announced that new preclinical study data supporting the potential safety and long-term efficacy of PBGENE-DMD has been selected as a poster presentation at the upcoming 2026 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference taking plac...

NEW YORK--(BUSINESS WIRE)--Moody's Corporation (NYSE: MCO) today announced results for the fourth quarter and full year 2025 and provided its outlook for full year 2026. The Fourth Quarter and Full Year 2025 Earnings Release and other earnings materials can be found on the Moody’s IR website at ir.moodys.com. In addition, the Earnings Release will be furnished with the Securities and Exchange Commission (SEC) on a Form 8-K and will be available on the SEC website at www.sec.gov. Teleconference...